OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001591165

Innoveren Scientific, Inc.

Innoveren Scientific, Inc. (CIK 0001591165, EIN 46-3312262) reported revenue of $453,460 for FY2022 (2022-01-01 to 2022-12-31) and net income of -$10.3 million (-$10,299,580) for FY2022 (2022-01-01 to 2022-12-31), as filed in its 10-K filed 2023-05-10 (accession 0001493152-23-016145).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001591165
EIN46-3312262
SIC industry code3841 Surgical & Medical Instruments & Apparatus
State or country of incorporationNV
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_3axnbhj7wcpq62qzbzcjnrvhdy
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$453,460FY20222022-01-01 to 2022-12-3110-K2023-05-100001493152-23-016145RevenueFromContractWithCustomerExcludingAssessedTax
Net income-$10,299,580FY20222022-01-01 to 2022-12-3110-K2023-05-100001493152-23-016145NetIncomeLoss
Total assets$137,357FY2022as of 2022-12-3110-K2023-05-100001493152-23-016145Assets
Total liabilities$9,494,743FY2022as of 2022-12-3110-K2023-05-100001493152-23-016145Liabilities
Stockholders' equity-$9,357,386FY2022as of 2022-12-3110-K2023-05-100001493152-23-016145StockholdersEquity
Operating cash flow-$1,913,738FY20222022-01-01 to 2022-12-3110-K2023-05-100001493152-23-016145NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$0.03 per shareFY20212021-01-01 to 2021-12-3110-K2022-02-250001493152-22-005486EarningsPerShareBasicAndDiluted
Shares outstanding628,122 sharesFY2022as of 2023-05-0910-K2023-05-100001493152-23-016145EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2013-2022, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20222022-01-01 to 2022-12-31$453,46010-K2023-05-100001493152-23-016145
RevenueFY20212021-01-01 to 2021-12-31$1,611,51810-K2023-05-100001493152-23-016145
RevenueFY20202020-01-01 to 2020-12-31$2,150,67210-K2022-02-250001493152-22-005486
RevenueFY20192019-01-01 to 2019-12-31$8,346,85810-K2021-03-250001493152-21-006836
RevenueFY20182018-01-01 to 2018-12-31$7,883,11510-K2020-04-220001493152-20-006936
RevenueFY20172017-01-01 to 2017-12-31$207,39610-K2018-03-300001493152-18-004286
RevenueFY20152015-01-01 to 2015-12-31$33,04510-K2016-04-140001415889-16-005540
Net incomeFY20222022-01-01 to 2022-12-31-$10,299,58010-K2023-05-100001493152-23-016145
Net incomeFY20212021-01-01 to 2021-12-31-$4,799,30710-K2023-05-100001493152-23-016145
Net incomeFY20202020-01-01 to 2020-12-31-$6,459,23610-K2022-02-250001493152-22-005486
Net incomeFY20192019-01-01 to 2019-12-31-$29,807,87810-K2021-03-250001493152-21-006836
Net incomeFY20182018-01-01 to 2018-12-31-$4,394,14910-K2020-04-220001493152-20-006936
Net incomeFY20172017-01-01 to 2017-12-31-$6,456,47710-K2019-04-100001493152-19-005081
Net incomeFY20162016-01-01 to 2016-12-31-$16,227,48410-K2018-03-300001493152-18-004286
Net incomeFY20152015-01-01 to 2015-12-31-$6,523,07710-K2017-03-310001654954-17-002874
  • Revenue for FY2018 was restated: first reported as $818,211 (accession 0001493152-19-005081, filed 2019-04-10).
  • Net income for FY2018 was restated: first reported as -$4,908,644 (accession 0001493152-19-005081, filed 2019-04-10).

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2023-11-152023-09-300001493152-23-041399form10-q.htm
10-Q2023-11-152023-06-300001493152-23-041344form10-q.htm
10-Q2023-05-222023-03-310001493152-23-018504form10-q.htm
10-K2023-05-102022-12-310001493152-23-016145form10-k.htm
10-Q2022-11-142022-09-300001493152-22-031927form10-q.htm
10-Q2022-08-122022-06-300001493152-22-022301form10-q.htm
10-Q2022-05-042022-03-310001493152-22-012070form10-q.htm
10-K2022-02-252021-12-310001493152-22-005486form10-k.htm
10-Q2021-11-122021-09-300001493152-21-028047form10-q.htm
10-Q2021-08-132021-06-300001493152-21-019638form10-q.htm
10-Q/A2021-07-062021-03-310001493152-21-016273form10-qa.htm
10-Q2021-05-132021-03-310001493152-21-011288form10-q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001591165published by the sourcedata.sec.gov/submissions/CIK0001591165.json2026-10-21
Employer Identification Number (EIN) · US-EIN46-3312262published by the sourcedata.sec.gov/submissions/CIK0001591165.json2026-10-21

Former names

NameFromTo
H-CYTE, INC.2019-04-292023-05-22
Medovex Corp.2014-05-282019-06-26
SpineZ2013-11-132014-05-01

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001591165.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001591165.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001591165" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001591165/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001591165/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1591165"}

On SEC EDGAR

About this data